InsiderTrades

Form 4 for MRSH Marsh McLennan

Accepted 2026-03-05 00:00:00 ET · period of report 2026-03-04 · accession 0000062709-26-000065 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-03-05 2026-03-04 MRSH Doyle John Q Pres, CEO S - Sale+OE $183.30 -16.7K 116.8K -12% -$3.05M
D 2026-03-05 2026-03-04 MRSH Doyle John Q Pres, CEO M - OptEx $0.00 +16.7K 133.5K +14% $0
D 2026-03-05 2026-03-04 MRSH Doyle John Q Pres, CEO M - OptEx $0.00 -16.7K 50.0K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-04 S D 16,655 $183.30 116,811.02 D — —
2 Common Common Stock 2026-03-04 M A 16,655 $0.00 133,466.02 D — —
3 Derivative Stock Options (Right to Buy) 2026-03-04 M D 16,655 $0.00 49,968 D $73.20 · — to 2027-02-21 16,655 Common Stock (F2) These options were granted on February 22, 2017 and vested in four equal annual installments on February 22nd of 2018, 2019, 2020 and 2021.